|Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart.|
|PMID: 18787169 Owner: NLM Status: MEDLINE|
|There is substantial interest in the development of drugs that limit the extent of ischemia-induced cardiac damage caused by myocardial infarction or by certain surgical procedures. Here, using an unbiased proteomic search, we identified mitochondrial aldehyde dehydrogenase 2 (ALDH2) as an enzyme whose activation correlates with reduced ischemic heart damage in rodent models. A high-throughput screen yielded a small-molecule activator of ALDH2 (Alda-1) that, when administered to rats before an ischemic event, reduced infarct size by 60%, most likely through its inhibitory effect on the formation of cytotoxic aldehydes. In vitro, Alda-1 was a particularly effective activator of ALDH2*2, an inactive mutant form of the enzyme that is found in 40% of East Asian populations. Thus, pharmacologic enhancement of ALDH2 activity may be useful for patients with wild-type or mutant ALDH2 who are subjected to cardiac ischemia, such as during coronary bypass surgery.|
|Che-Hong Chen; Grant R Budas; Eric N Churchill; Marie-Hélène Disatnik; Thomas D Hurley; Daria Mochly-Rosen|
Related Documents :
|24473199 - Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion...
16189049 - Trans-sternal cardiac injury caused by a hooked needle.
1646829 - High-performance liquid chromatographic detection of hydroxylated benzoic acids as an i...
8720909 - Protective effects of the k+ atp channel opener, aprikalim, against free radicals in is...
20935489 - Autophagy in aldh2-elicited cardioprotection against ischemic heart disease: slayer or ...
15620989 - Hydrodissection in redo sternotomies.
3356079 - Postinfarction left ventricular pseudoaneurysm: echocardiographic diagnosis and prolong...
6391399 - Comparison of operative mortality and morbidity for initial and repeat coronary artery ...
606859 - Small cardiac lesions. fibrosis of papillary muscles and focal cardiac myocytolysis.
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't|
|Title: Science (New York, N.Y.) Volume: 321 ISSN: 1095-9203 ISO Abbreviation: Science Publication Date: 2008 Sep|
|Created Date: 2008-09-12 Completed Date: 2008-09-25 Revised Date: 2014-09-09|
Medline Journal Info:
|Nlm Unique ID: 0404511 Medline TA: Science Country: United States|
|Languages: eng Pagination: 1493-5 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
antagonists & inhibitors,
Aldehydes / metabolism
Amino Acid Sequence
Benzamides / pharmacology*
Benzodioxoles / pharmacology*
Cardiotonic Agents / pharmacology*
Cyanamide / pharmacology
Ethanol / pharmacology
Ischemic Preconditioning, Myocardial
Mitochondrial Proteins / agonists, antagonists & inhibitors, metabolism*
Molecular Sequence Data
Myocardial Infarction / enzymology, pathology, prevention & control*
Myocardial Reperfusion Injury / enzymology*
Myocardium / enzymology*, pathology
Nitroglycerin / pharmacology
Protein Kinase C-epsilon / metabolism
|AA11147/AA/NIAAA NIH HHS; R01 AA011147/AA/NIAAA NIH HHS; R01 AA011147-08/AA/NIAAA NIH HHS; R01 AA011147-09/AA/NIAAA NIH HHS; R01 AA011147-10/AA/NIAAA NIH HHS; R01 AA011147-11/AA/NIAAA NIH HHS; R01 AA011147-12/AA/NIAAA NIH HHS|
|0/Aldehydes; 0/Benzamides; 0/Benzodioxoles; 0/Cardiotonic Agents; 0/Mitochondrial Proteins; 0/N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide; 29343-52-0/4-hydroxy-2-nonenal; 3K9958V90M/Ethanol; 420-04-2/Cyanamide; EC 220.127.116.11/Aldehyde Dehydrogenase; EC 18.104.22.168/Aldh2 protein, rat; EC 22.214.171.124/Protein Kinase C-epsilon; G59M7S0WS3/Nitroglycerin|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Degradation of microRNAs by a family of exoribonucleases in Arabidopsis.
Next Document: FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.